Record Information
Version1.0
Creation Date2014-08-29 06:51:40 UTC
Update Date2016-11-09 01:09:08 UTC
Accession NumberCHEM003449
Identification
Common NameCoumaphos
ClassSmall Molecule
DescriptionCoumaphos is a nonvolatile, fat-soluble phosphorothioate with ectoparasiticide properties: it kills insects and mites. It is well known by a variety of brand names as a dip or wash, used on farm and domestic animals to control ticks, mites, flies and fleas.
Contaminant Sources
  • Clean Air Act Chemicals
  • My Exposome Chemicals
  • STOFF IDENT Compounds
  • Suspected Compounds
  • T3DB toxins
  • ToxCast & Tox21 Chemicals
Contaminant Type
  • Acaricide
  • Ester
  • Insecticide
  • Organic Compound
  • Organochloride
  • Pesticide
  • Synthetic Compound
Chemical Structure
Thumb
Synonyms
ValueSource
3-Chloro-4-methyl-7-coumarinyl diethyl phosphorothioateChEBI
3-Chloro-4-methyl-7-hydroxycoumarin diethyl thiophosphoric acid esterChEBI
3-Chloro-7-diethoxyphosphinothioyloxy-4-methylcoumarinChEBI
3-Chloro-7-hydroxy-4-methyl-coumarin O,O-diethyl phosphorothioateChEBI
O,O-Diethyl 3-chloro-4-methyl-7-umbelliferone thiophosphateChEBI
O,O-Diethyl O-(3-chloro-4-methyl-2-oxo-2H-1-benzopyran-7-yl)phosphorothioateChEBI
O-(3-Chloro-4-methyl-2-oxo-2H-chromen-7-yl) O,O-diethyl thiophosphateChEBI
Phosphorothioic acid, O-(3-chloro-4-methyl-2-oxo-2H-1-benzopyran-7-yl) O,O-diethyl esterChEBI
MeldaneKegg
3-Chloro-4-methyl-7-coumarinyl diethyl phosphorothioic acidGenerator
3-Chloro-4-methyl-7-hydroxycoumarin diethyl thiophosphate esterGenerator
3-Chloro-7-hydroxy-4-methyl-coumarin O,O-diethyl phosphorothioic acidGenerator
O,O-Diethyl 3-chloro-4-methyl-7-umbelliferone thiophosphoric acidGenerator
O,O-Diethyl O-(3-chloro-4-methyl-2-oxo-2H-1-benzopyran-7-yl)phosphorothioic acidGenerator
O-(3-Chloro-4-methyl-2-oxo-2H-chromen-7-yl) O,O-diethyl thiophosphoric acidGenerator
Phosphorothioate, O-(3-chloro-4-methyl-2-oxo-2H-1-benzopyran-7-yl) O,O-diethyl esterGenerator
AsuntolMeSH
CoumafosMeSH
Chemical FormulaC14H16ClO5PS
Average Molecular Mass362.766 g/mol
Monoisotopic Mass362.014 g/mol
CAS Registry Number56-72-4
IUPAC NameO-3-chloro-4-methyl-2-oxo-2H-chromen-7-yl O,O-diethyl phosphorothioate
Traditional Namemeldane
SMILESCCOP(=S)(OCC)OC1=CC2=C(C=C1)C(C)=C(Cl)C(=O)O2
InChI IdentifierInChI=1S/C14H16ClO5PS/c1-4-17-21(22,18-5-2)20-10-6-7-11-9(3)13(15)14(16)19-12(11)8-10/h6-8H,4-5H2,1-3H3
InChI KeyBXNANOICGRISHX-UHFFFAOYSA-N
Chemical Taxonomy
Description belongs to the class of organic compounds known as coumarins and derivatives. These are polycyclic aromatic compounds containing a 1-benzopyran moiety with a ketone group at the C2 carbon atom (1-benzopyran-2-one).
KingdomOrganic compounds
Super ClassPhenylpropanoids and polyketides
ClassCoumarins and derivatives
Sub ClassNot Available
Direct ParentCoumarins and derivatives
Alternative Parents
Substituents
  • Coumarin
  • Aryl thiophosphate
  • Benzopyran
  • 1-benzopyran
  • Thiophosphate triester
  • Pyranone
  • Aryl chloride
  • Aryl halide
  • Thiophosphoric acid ester
  • Benzenoid
  • Organic thiophosphoric acid or derivatives
  • Pyran
  • Heteroaromatic compound
  • Lactone
  • Organoheterocyclic compound
  • Oxacycle
  • Organochloride
  • Organohalogen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Organic oxygen compound
  • Organooxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginExogenous
Cellular Locations
  • Cell surface
  • Membrane
  • Nerve Fiber
Biofluid LocationsNot Available
Tissue LocationsNot Available
Pathways
NameSMPDB LinkKEGG Link
TetracyclinesNot AvailableNot Available
Applications
Biological Roles
Chemical Roles
Physical Properties
StateSolid
AppearanceWhite powder.
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted Properties
PropertyValueSource
Water Solubility0.0015 g/LALOGPS
logP4.5ALOGPS
logP4.15ChemAxon
logS-5.4ALOGPS
pKa (Strongest Basic)-7.3ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count1ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area53.99 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity89.93 m³·mol⁻¹ChemAxon
Polarizability34.61 ųChemAxon
Number of Rings2ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyView
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QTOF , positivesplash10-03di-0009000000-1eb96120bb8c3511912eSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QTOF , positivesplash10-0bw9-0039000000-13c6f9257fbc11ac5878Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QTOF , positivesplash10-004i-0091000000-5f535054f0f4f1d40167Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QTOF , positivesplash10-004i-0090000000-c875939d86ddad0a8e08Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QTOF , positivesplash10-004i-0590000000-878fbf88eb9b1468b002Spectrum
LC-MS/MSLC-MS/MS Spectrum - 50V, Positivesplash10-004i-0590000000-878fbf88eb9b1468b002Spectrum
LC-MS/MSLC-MS/MS Spectrum - 60V, Positivesplash10-002b-6690000000-0b075949b4fc64417b45Spectrum
LC-MS/MSLC-MS/MS Spectrum - 75V, Positivesplash10-002b-3930000000-afb7f841e4d8f9374a10Spectrum
LC-MS/MSLC-MS/MS Spectrum - 60V, Positivesplash10-004j-6690000000-e4dbfc7cf2aa396974cbSpectrum
LC-MS/MSLC-MS/MS Spectrum - 40V, Positivesplash10-004i-0090000000-05ecad535abaa608b26fSpectrum
LC-MS/MSLC-MS/MS Spectrum - 90V, Positivesplash10-0002-5900000000-87869720e427b6ae2f4dSpectrum
LC-MS/MSLC-MS/MS Spectrum - 30V, Positivesplash10-004i-0091000000-fa3c3a4750e37d943301Spectrum
LC-MS/MSLC-MS/MS Spectrum - 50V, Positivesplash10-004i-0590000000-89c84cbf0e4cff0420d3Spectrum
LC-MS/MSLC-MS/MS Spectrum - 15V, Positivesplash10-03di-0209000000-b115f399660285d47a7cSpectrum
LC-MS/MSLC-MS/MS Spectrum - 45V, Positivesplash10-0002-7491000000-17d6540e989451a469d4Spectrum
LC-MS/MSLC-MS/MS Spectrum - 30V, Positivesplash10-056r-1396000000-1b6df76eac4b3635ae59Spectrum
LC-MS/MSLC-MS/MS Spectrum - 20V, Positivesplash10-0bw9-0039000000-13c6f9257fbc11ac5878Spectrum
LC-MS/MSLC-MS/MS Spectrum - 30V, Positivesplash10-004i-0091000000-6939f400c7b0e0135314Spectrum
LC-MS/MSLC-MS/MS Spectrum - 10V, Positivesplash10-03di-0009000000-5fe0783ca5e8f6cf5a52Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-03e9-0009000000-803a80ca33dda23dc6aaSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-0bu0-1129000000-00264c0e462527baf311Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-0hkm-4940000000-213ceacd491055ba0ef5Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-03e9-0129000000-a5bf355fe65815e55f3fSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-01q9-0229000000-ba2d0f5d2138ff62e801Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-0k9i-0968000000-a999b49b42dee23cdc87Spectrum
MSMass Spectrum (Electron Ionization)splash10-06vj-7954000000-80e126f971975f223e60Spectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
Toxicity Profile
Route of ExposureNot Available
Mechanism of ToxicityCoumaphos is a cholinesterase or acetylcholinesterase (AChE) inhibitor. A cholinesterase inhibitor (or 'anticholinesterase') suppresses the action of acetylcholinesterase. Because of its essential function, chemicals that interfere with the action of acetylcholinesterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses, followed by muscle spasms and ultimately death. Nerve gases and many substances used in insecticides have been shown to act by binding a serine in the active site of acetylcholine esterase, inhibiting the enzyme completely. Acetylcholine esterase breaks down the neurotransmitter acetylcholine, which is released at nerve and muscle junctions, in order to allow the muscle or organ to relax. The result of acetylcholine esterase inhibition is that acetylcholine builds up and continues to act so that any nerve impulses are continually transmitted and muscle contractions do not stop. Among the most common acetylcholinesterase inhibitors are phosphorus-based compounds, which are designed to bind to the active site of the enzyme. The structural requirements are a phosphorus atom bearing two lipophilic groups, a leaving group (such as a halide or thiocyanate), and a terminal oxygen.
MetabolismMetabolism of organophosphates occurs principally by oxidation, by hydrolysis via esterases and by reaction with glutathione. Demethylation and glucuronidation may also occur. Oxidation of organophosphorus pesticides may result in moderately toxic products. In general, phosphorothioates are not directly toxic but require oxidative metabolism to the proximal toxin. The glutathione transferase reactions produce products that are, in most cases, of low toxicity. Paraoxonase (PON1) is a key enzyme in the metabolism of organophosphates. PON1 can inactivate some organophosphates through hydrolysis. PON1 hydrolyzes the active metabolites in several organophosphates insecticides as well as, nerve agents such as soman, sarin, and VX. The presence of PON1 polymorphisms causes there to be different enzyme levels and catalytic efficiency of this esterase, which in turn suggests that different individuals may be more susceptible to the toxic effect of organophosphate exposure.
Toxicity ValuesNot Available
Lethal DoseNot Available
Carcinogenicity (IARC Classification)No indication of carcinogenicity to humans (not listed by IARC).
Uses/SourcesThis is a man-made compound that is used as a pesticide.
Minimum Risk LevelNot Available
Health EffectsAcute exposure to cholinesterase inhibitors can cause a cholinergic crisis characterized by severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Accumulation of ACh at motor nerves causes overstimulation of nicotinic expression at the neuromuscular junction. When this occurs symptoms such as muscle weakness, fatigue, muscle cramps, fasciculation, and paralysis can be seen. When there is an accumulation of ACh at autonomic ganglia this causes overstimulation of nicotinic expression in the sympathetic system. Symptoms associated with this are hypertension, and hypoglycemia. Overstimulation of nicotinic acetylcholine receptors in the central nervous system, due to accumulation of ACh, results in anxiety, headache, convulsions, ataxia, depression of respiration and circulation, tremor, general weakness, and potentially coma. When there is expression of muscarinic overstimulation due to excess acetylcholine at muscarinic acetylcholine receptors symptoms of visual disturbances, tightness in chest, wheezing due to bronchoconstriction, increased bronchial secretions, increased salivation, lacrimation, sweating, peristalsis, and urination can occur. Certain reproductive effects in fertility, growth, and development for males and females have been linked specifically to organophosphate pesticide exposure. Most of the research on reproductive effects has been conducted on farmers working with pesticides and insecticdes in rural areas. In females menstrual cycle disturbances, longer pregnancies, spontaneous abortions, stillbirths, and some developmental effects in offspring have been linked to organophosphate pesticide exposure. Prenatal exposure has been linked to impaired fetal growth and development. Neurotoxic effects have also been linked to poisoning with OP pesticides causing four neurotoxic effects in humans: cholinergic syndrome, intermediate syndrome, organophosphate-induced delayed polyneuropathy (OPIDP), and chronic organophosphate-induced neuropsychiatric disorder (COPIND). These syndromes result after acute and chronic exposure to OP pesticides.
SymptomsSymptoms of low dose exposure include excessive salivation and eye-watering. Acute dose symptoms include severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Hypertension, hypoglycemia, anxiety, headache, tremor and ataxia may also result.
TreatmentIf the compound has been ingested, rapid gastric lavage should be performed using 5% sodium bicarbonate. For skin contact, the skin should be washed with soap and water. If the compound has entered the eyes, they should be washed with large quantities of isotonic saline or water. In serious cases, atropine and/or pralidoxime should be administered. Anti-cholinergic drugs work to counteract the effects of excess acetylcholine and reactivate AChE. Atropine can be used as an antidote in conjunction with pralidoxime or other pyridinium oximes (such as trimedoxime or obidoxime), though the use of '-oximes' has been found to be of no benefit, or possibly harmful, in at least two meta-analyses. Atropine is a muscarinic antagonist, and thus blocks the action of acetylcholine peripherally.
Concentrations
Not Available
DrugBank IDDB11390
HMDB IDHMDB0250488
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkCoumaphos
Chemspider ID2768
ChEBI ID3903
PubChem Compound ID2871
Kegg Compound IDC11025
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available